VERA THERAPEUTICS, INC. (VERA)
Clinical trial NCT06674577 updates: 1. completion date: 2028-05-31 → 2031-05-21 2. primary completion date: 2028-05-31 → 2031-05-21 3. enrollment: 476 → 750 participants
Clinical trial NCT06674577 updates: 1. completion date: 2028-05-31 → 2031-05-21 2. primary completion date: 2028-05-31 → 2031-05-21 3. enrollment: 476 → 750 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical